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Abstract
We have derived hESC from biopsied blastomeres of cleavage stage embryos under virtually the same conditions we used
for the derivation of hESC lines from inner cell mass of blastocyst stage embryos. Blastomere-derived hESC lines exhibited all
the standard characteristics of hESC including undifferentiated proliferation, genomic stability, expression of pluripotency
markers and the ability to differentiate into the cells of all three germ layers both in vitro and in vivo. To examine whether
hESC lines derived from two developmental stages of the embryo differ in gene expression, we have subjected three
blastomere-derived hESC lines and two ICM-derived hESC lines grown under identical culture conditions to transcriptome
analysis using gene expression arrays. Unlike previously reported comparisons of hESC lines which demonstrated, apart
from core hESC-associated pluripotency signature, significant variations in gene expression profiles of different lines, our
data show that hESC lines derived and grown under well-controlled defined culture conditions adopt nearly identical gene
expression profiles. Moreover, blastomere-derived and ICM-derived hESC exhibited very similar transcriptional profiles
independent of the developmental stage of the embryo from which they originated. Furthermore, this profile was evident
in very early passages of the cells and did not appear to be affected by extensive passaging. These results suggest that
during derivation process cells which give rise to hESC acquire virtually identical stable phenotype and are not affected by
the developmental stage of the starting cell population.
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Introduction
Totipotency in human embryos persists until 4–8 cell stage
[1,2]. Subsequently, genome activation initiates differentiation,
with certain blastomeres forming the outer, polar, trophectoderm
while others retain their pluripotent potential and generate the
non-polar inner cell mass that will give rise to the future organism.
These two morphologically distinct cell populations continue to
divide as they form the blastocyst, and can easily be physically
separated. Human embryonic stem cells (hESC) are typically
derived from the pluripotent inner cell mass cells of the blastocyst
[3]. More recently, we and others have reported alternative
method of hESC derivation from biopsied blastomeres isolated
from 8-cell/cleavage stage embryos [4,5]. While blastomeres of the
8-cell stage embryo and the cells of the ICM show some biological
similarities, including a non-polarized phenotype and pluripotent
potential, they also exhibit significant differences. Indeed, micro-
array analysis of gene expression during six developmental stages
of human preimplantation embryos showed a group of 2299 probe
sets differentially expressed in blastocyst stage compared to 8-cell
stage embryos [6]. The majority of these genes were involved in
lipid and fatty acid metabolism. In addition, a group of 1715 probe
sets involved in the regulation of transcription and nucleic acid
metabolism were down-regulated in blastocysts compared to 8 cell
stage embryos [6]. Furthermore, the DNA of the blastomeres of
the 8 cell stage embryos is completely demethylated as a result of
reprogramming and activation of embryonic genome whereas the
methylation marks are already re-established in the cells of the
ICM [7]. In addition, blastomeres of the 8-cell stage embryo
exhibit lower telomerase activity and shorter average telomere
length than cells in the ICM [8].
During the derivation process, hESC acquire a polarized
phenotype, a characteristic not present in the pluripotent mouse
ESC [9]. Indeed, they appear closer to mouse stem cells derived
from primitive ectoderm than those from the inner cell mass.
Similarly, the active molecular signaling pathways in hESC
resemble those of mouse epiblast stem cells derived from post-
implantation embryo [10]. This indicates that hESC derived from
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development. Hence, we investigated whether human stem cell
lines derived from late totipotent blastomeres of the cleavage stage
embryo develop a more ‘‘primitive’’ phenotype than ICM-derived
lines by profiling their respective gene expression, molecular
regulation and signaling pathways. In this study, we examined
whether the inherent differences in the developmental stage of the
starting embryonic cell population are maintained in the derived
hESC lines by evaluating the stemness, differentiation capacity
and gene expression profiles of blastomere- and ICM-derived
hESC lines.
Materials and Methods
Ethics Statement
Derivation of hESC lines has been conducted in accordance
with the study protocol approved by Western Institutional Review
Board (WIRB).
Derivation and culture of hESC
Three human embryonic stem cell (hESC) lines were derived
from biopsied blastomeres of 2 surplus frozen human cleavage
stage embryos donated by two consenting couples that provided
written consent according to the protocol approved by WIRB.
These lines (W10, SAB-113B, and SAB-113D) were derived using
established derivation procedure in our laboratory (illustrated in
Fig. 1). Briefly, the embryos were thawed and incubated in
Quinn’s cleavage medium for minimum 3 h at standard culture
conditions. Blastomeres were removed from each embryo using
established biopsy procedure [11]. Each biopsied blastomere was
cultured in a 20 ml drop of Quinn’s cleavage medium in an
incubator at 37 uC. After 24 h incubation, the blastomeres were
transferred onto irradiated human foreskin fibroblast (HFF)
feeders in 50 ml drops of Quinn’s cleavage medium supplemented
with human laminin (10 mg/ml; day 0). Three days later cultures
were assessed for blastomere attachment to feeders. Starting on
day 3, medium in drops containing attached blastomeres has been
refreshed every day by replacing 1/3 of volume with Quinn’s
blastocyst medium supplemented with human laminin (10 mg/ml),
recombinant human leukemia inhibitory factor (LIF; 10 ng/ml),
and recombinant human basic fibroblast growth factor (FGF;
25 ng/ml; R&D Systems, Inc.). From day 5, Quinn’s blastocyst
medium was replaced with standard hESC medium (80% KO-
DMEM, 20% KSR, FGF-25 ng/ml, and LIF-10 ng/ml), and
replaced in drops daily. Embryonic stem cell-certified fetal calf
serum (10%) was added to the medium for a week. On day 11,
initial hESC colonies were dissected and left in the same drop. On
day 14, colonies were dissected and transferred into 4-well dish
with new HFF feeders. From the next day onwards the cells were
cultured in standard hESC medium containing FGF (25 ng/ml)
and LIF (10 ng/ml).
Immunocytochemistry and alkaline phosphatase assay
The expression of pluripotency markers such as OCT4,
NANOG, SSEA4, TRA-1-60 and TRA-1-81, and the differenti-
ation markers of all 3 germ layers such as b-III tubulin, smooth
muscle actin and a-feto protein, were evaluated by immunocyto-
chemical analysis. Briefly, hESC colonies and differentiated cells
were fixed in 4% paraformaldehyde (PFA) or 90% acetone at
room temperature for 10 min. The PFA-fixed cells were
permeabilized in 0.1% Triton at room temperature for 10 min.
The cells were then, incubated with primary antibodies overnight
at 4 uC, and stained with fluorescent dye-conjugated donkey
secondary antibodies. The immunostained cells were mounted in
Vectashield (Vector Laboratories, Inc., Burlingame, CA, USA)
and evaluated under fluorescent microscope (Nikon Eclipse 50i,
Nikon Instruments Inc., Melville, NY, USA). To evaluate the
expression and activity of alkaline phosphatase in the undifferen-
tiated hESC, ELF Phosphatase Detection Kit (ATCC, Manassas,
VA, USA) was used and the kit manufacturer’s instructions were
followed. Briefly, the cells were fixed in 4% PFA at room
temperature for 10 min and permeabilized in 0.2% Tween-20
solution at room temperature for 10 min. Next, the substrate was
added and incubated at room temperature. After 5 min
Figure 1. Derivation of hESC from biopsied blastomere of the cleavage stage embryo. Micrographs showing the stepwise procedure of
embryo biopsy using inverted microscope-attached micromanipulator (A–D) and the appearance of initial outgrowth and hESC colony during the
derivation procedure (E–L). All pictures were taken using microscope mounted digital camera and Hoffman optics under 200X total magnification.
doi:10.1371/journal.pone.0026570.g001
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times using wash buffer. Cells were mounted and observed under
fluorescent microscope.
Flow cytometry
Flow cytometry was performed using PerCP-Cy5.5 conjugated
anti-human OCT4 antibody and PE conjugated anti-human
NANOG antibody (BD Biosciences, San Jose, CA, USA) and
fixation and permeabilization reagents A and B (Invitrogen Corp.,
Carlsbad, CA, USA). hESC colonies were accutase treated (to
separate into single cells) and fixed in reagent A at room
temperature for 15 min. Next, cells were permeabilized in reagent
B at room temperature for 5 min and incubated with antibodies at
4 uC for 20 min. The cells were resuspended in sheath fluid and
flow cytometry was performed using a flow cytometer (BD LSR II,
BD Biosciences).
In vitro and in vivo differentiation of hESC
For in vitro differentiation, colonies were cultured on feeders in
standard hESC medium containing 10% fetal bovine serum
without FGF. After 2–3 week differentiation, cells were fixed in
4% paraformaldehyde (PFA) for immunocytochemistry. Cells were
also collected for RNA extraction and RT-PCR was performed to
evaluate the expression of differentiation markers. For in vivo
differentiation, 5–6 million hESC were mixed with 30% matrigel
and transferred on ice to Jackson West animal facility (The Jackson
Laboratory – West, Sacramento, CA, USA) where they were
subcutaneously injected under the dorsal flank of immunocom-
promised NOD/SCID mice. The animals were observed for
teratoma formation and sacrificed 3 months after injection.
Histopathological analysis was performed on the sections of the
teratoma to verify the formation of tissues from all three germ
layers and lack of invasive tumors.
RNA extraction and RT-PCR
RNA was isolated using RNAeasy Plus Minikit (Qiagen Inc.,
Valencia, CA, USA) and converted to cDNA using SuperScript III
CellsDirect cDNA Synthesis System (Invitrogen). The polymerase
chain reaction (PCR) was performed using Platinum PCR
SuperMix (Invitrogen) and primers for transcripts of markers
from all three germ layers: T (Brachyury protein), WT1 (Wilms
tumor) and ACTA2 (smooth muscle actin, a2) were chosen as
markers of mesoderm, GATA4 (GATA binding protein 4), SOX17
(sex determining region Y – box 17) and AFP (a fetoprotein) as
markers of endoderm, and TUBB3 (Tubulin, b3), NES (nestin) and
PAX6 (paired box 6) as markers of ectoderm. The PCR products
were analyzed by gel electrophoresis using ethidium bromide
(1 mg/mL) stained 2% agarose gels and photographed under
ultraviolet illumination. The primer sequence, annealing temper-
ature, number of PCR cycles and fragment size are provided in
Table S1.
Karyotype analysis
Karyotype analysis (G banding) of each hESC line has been
performed at certified Cytogenetics Laboratory, Children’s
Hospital and Research Center, Oakland, CA, USA on early and
later passages of each hESC line.
Cell culture and sample collection
Samples from 3 of the blastomere derived hESC lines (SAB-
113B, SAB-113D and W10), and 2 of the whole embryo derived
hESC lines (SG4 and SG7) established in our laboratory were
collected for microarray analysis. All the selected hESC lines were
adjusted to grow under feeder-free defined culture conditions on
defined human matrix (CellStart, Invitrogen)-coated dishes in
StemPro SFM serum-free hESC medium (Invitrogen) containing
FGF (10 ng/ml), and passaged using accutase (Millipore, Teme-
cula, CA, USA) for enzymatic cell separation. For each hESC line,
cells were collected when the colonies showed 70–80% confluency
in three biological replicates for SAB-113B and SAB-113D lines
and 2 replicates for W10, SG4 and SG7 lines. Cells were washed
once in DPBS, pelleted, snap frozen in liquid nitrogen and stored
at 280 uC. Frozen cell pellet samples and human universal
reference total RNA from 2 different lot numbers (Catalog
number 636538, Clontech, Mountain View, CA, USA) were sent
to Expression Analysis (Expression Analysis, Inc., Durham, NC,
USA) to conduct microarray analysis using Human Genome U133
Plus 2.0 gene chips (Affymetrix, Santa Clara, CA, USA).
Microarray data analysis
Statistical analysis was carried out with Affymetrix CEL files
using the software environment R (http://www.r-project.org/)
and the Bioconductor packages implemented within affylmGUI
[12,13]. In order to remove possible sources of variation of a non-
biological origin between arrays, intensity values between arrays
were normalised using the robust multiarray averaging (RMA) and
log2 expression values exported [14]. The top 10,000 probe sets
(based on summed median difference from reference RNA) were
subject to unsupervised hierarchical clustering (with sample/probe
leaf ordering optimized, Pearson correlation, average link
clustering) using MeV (http://www.tigr.org/) [15]. The top 25
and bottom 25 genes are presented. Differential expression of
genes between treatment groups was determined by linear
modelling and empirical Bayes statistics. Differentially expressed
genes were selected using a fold-change cut-off value of 2 and
above, BH corrected p score of less than 0.01, and a B score of
more than 5. Functional annotations were carried out using
Affymetrix annotation data to identify overrepresented gene
ontology functions of uniquely expressed genes in blastomere
and whole embryo derived hESC lines compared to reference
RNA. Ingenuity Pathways Analysis platform (http://www.
ingenuity.com/) was used to identify the statistically significant
genes involved in the pathways of stemness regulated by OCT4 and
NANOG, in lines of both origins compared to reference RNA.
Results
Derivation and characterization of hESC lines from
biopsied blastomeres of the cleavage stage embryo
Using previously described methods for blastomere biopsy and
hESC derivation on human feeders, we have derived two new
hESC lines from biopsied blastomeres of cleavage (8-cell) stage
embryos (Fig. 1). These newly derived hESC lines, SAB-113B and
SAB-113D, expressed known markers of stemness including
OCT4, NANOG, SSEA4, TRA-1-60, TRA-1-81 as determined
by immunocytochemical analysis and exhibited alkaline phospha-
tase activity (Fig. 2A, 2B). Similar results have already been
obtained for previously derived blastomere line W10 [4] and
whole embryo lines SG4 and SG7 (data not shown). Next, we
compared normalized expression of 14 established hESC stemness
genes (DNMT3B, DPPA2, DPPA4, GABRB3, GDF3, MYBL2,
NANOG, PHC1, POU5F1, SALL4, SOX2, TCF7L1, TERT and
ZFP42) in newly generated blastomere-derived SAB-113B and
SAB-113D lines, previously derived W10 blastomere line, and
whole embryo ICM-derived lines, SG4 and SG7, and observed
consistent high expression of all stemness genes examined and lack
of any major differences in their expression levels between
hESC from Two Embryonic Stages Share Transcriptome
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(Fig. 2C). Furthermore, FACS analysis showed that more than
80% of cells in blastomere-derived (Fig. 2D) and whole embryo
ICM-derived (data not shown) hESC lines expressed both OCT4
and NANOG. In addition, these lines also showed no significant
difference in growth rate, with approximate doubling time of 40 h
on feeders and 24 h under feeder-free conditions. Cell and colony
morphology was examined semiweekly by inverted microscopy
using phase contrast light and Hoffman optics and did not reveal
any significant differences between these lines. Newly derived
hESC lines exhibited stable normal male karyotype (46, XY) after
10 passages in culture (Fig. 2E, 2F) as examined by G-banding
analysis. Blastomere-derived W10 line showed a stable female
karyotype (46, XX) as previously reported and both whole embryo
SG4 and SG7 lines exhibited a stable normal male karyotype (46,
XY; data not shown).
In vitro and in vivo differentiation
hESC derived from the ICM of blastocyst stage embryos have
the inherent capacity to differentiated into tissues of all three germ
layers both in culture and when injected into the animals. To
examine whether our newly derived blastomere lines exhibit
similar pluripotent capacity, we have subjected SAB-113B and
SAB-113D lines to spontaneous in vitro differentiation and
teratoma formation in vivo. Differentiation in culture was
performed in serum-containing differentiation medium on human
matrix-coated plates. After 2–3 weeks of differentiation, cells were
examined by RT-PCR and immunocytochemical analysis to
determine expression of markers of all 3 germ layers. Our data
showed that upon differentiation, similarly to ICM-derived lines,
blastomere-derived lines also expressed markers of all three germ
layers (Fig. 3A–C). We have previously reported that the
differentiated products from blastomere-derived W10 line also
showed similar expression of markers of all 3 germ layers.
To assess in vivo differentiation capacity of blastomere-derived
lines, 5–6 million cells were subcutaneously injected under the
dorsal flank of immunocompromised NOD/ SCID mice and
tumors were extracted when they reached 100 mm
3. The
histopathological analyses of the teratomas revealed that the
hESC derived from blastomeres form benign tumors and
differentiate into tissues of all three germ layers (Fig. 3D).
Transcriptome analysis
We performed transcriptome analysis on two whole embryo-
derived lines (WED) from blastocyst-stage (SG4 and SG7) and
three single blastomere derived lines (SBD) from cleavage stage
embryos (SAB-113B, SAB-113D and W10). SAB-113B and SAB-
113D lines were derived from two different blastomeres of one
embryo and W10 line was derived from a single blastomere of
another embryo. The SG4 and SG7 lines were derived from ICM
of two different whole embryos. Three replicates of SAB-113B,
SAB-113D blastomere lines, and two replicates of W10 blastomere
line and SG4 and SG7 whole embryo lines, and human universal
reference total RNA from two different lot numbers were included
in the experiment. In order to minimize culture induced variations
in gene expression, all blastomere and whole embryo lines were
grown under identical defined feeder-free serum-free culturing
conditions on human matrix-coated surfaces. Cell pellets were
collected and RNA samples were generated from cells harvested
when the colonies reached 70–80% confluency to ensure similar
cell cycle profiles. Human Universal Reference Total RNA was
used as control to identify genes which are specifically over- and
under- expressed in hESC lines. These commercially available
RNA samples were made by pooling total RNA extracts from a
collection of different whole tissue sources, thus providing the
broadest coverage of expressed genes. The similarities and
differences between the single embryo derived (SBD) and whole
embryo derived (WED) lines were established by first comparing
each to the reference RNA, then performing a 4-way venn of the
identified up- and down-regulated genes. Of the 6894 and 6683
significantly different genes in SBD and WED respectively (relative
to reference RNA), some 6387 were shared (over 90%).
Specifically, 3405 genes were commonly up-regulated and 2982
were commonly down-regulated. None of the genes were
oppositely regulated (Fig. 4A). This indicates that less than 10%
of the genes may be uniquely expressed in ESC line of specific
origin.
Based on summed median difference of normalized expression
value of samples from reference RNA, the top 10,000 probe sets
were subject to unsupervised hierarchical clustering, with the
normalized expression values of top 25 overexpressed and top 25
underexpressed genes and sample dendrogram represented in
Figure 4B. Hierarchical clustering revealed that the SBD and
WED lines do not show a clear separation, indicating that hESC
lines grown under identical conditions share similar gene
expression profiles, independent of the developmental stage of
the embryo from which lines originate (Fig. 4B).
In both blastomere- and whole embryo-derived ESC lines, only
about one-quarter of the unique genes, whose expression differs
from reference RNA, were associated with an annotated biological
processes such as cell cycle, regulation of transcription, cell
differentiation, signaling, cell migration, apoptosis, cell adhesion
and cytoskeleton organization (as categorized by GO, as listed in
the Affymetrix gene annotation data). Thus, the potential role of
the majority of altered genes controlling the establishment and
maintenance of hESC phenotype remains to be elucidated
(Fig. 4C, 4D). It is quite likely that some of the expressed
transcripts do not have a functional role, are not translated and
could be by-product of the open chromatin structure. Among GO
annotated genes, signaling, apoptosis and cell adhesion showed
about 0.5 to 1.9% less unique genes in the blastomere-derived lines
compared to whole embryo-derived lines. While 0.7% of unique
genes from whole embryo lines were associated with cell
migration, blastomere derived lines did not have altered
expression of any of genes from this category. In blastomere
derived lines, there was 1% increase in unique genes associated
with cell cycle and 2.9% increase in genes involved in regulation of
transcription.
Figure 2. Expression of pluripotency genes in cleavage stage blastomere-derived and blastocyst stage ICM-derived hESC. SAB-113B
(A) and SAB-113D (B) cells express markers of pluripotency as shown by immunocytochemical analyses (OCT4, NANOG, SSEA-4, TRA 1-60, and TRA 1-
81) and alkaline phosphatase activity (AP). Insets of the images show the nuclei of the cells stained with HOECHST 33342. Normalized expression of
well-known 14 pluripotency genes (DNMT3B, DPPA2, DPPA4, GABRB3, GDF3, MYBL2, NANOG, PHC1, POU5F1, SALL4, SOX2, TCF7L1, TERT and ZFP42)i n
all the replicates of blastomere lines (SBD1, SBD2, SBD3, SBD4, SBD5, SBD6, SBD7 and SBD8), and whole embryo lines (WED1, WED2, WED3 and WED4)
showed consistent high values compared to reference RNA (ref) (C). Flow cytometric analysis of these lines also showed consistent high expression of
OCT4 and NANOG. Representative diagram for SAB-113B is depicted (D). In addition, SAB-113B (E) and SAB-113D (F) lines exhibited a stable male
karyotype (46, XY) after 10 passages in culture.
doi:10.1371/journal.pone.0026570.g002
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between blastomere and ICM-derived lines, direct pair-wise
comparison was performed. The analysis revealed only 36
annotated genes (20 genes upregulated in blastomere derived
lines relative to ICM-derived and 16 genes downregulated) were
significantly different between the lines of both origins (Fig. 5). Out
of these 36 genes, only 6 genes (3 upregulated - ZNF248, SOHLH2
and MAGEE1, and 3 downregulated - CLC, ZNF558 and
LGALS14) showed more than 4 fold changes in expression between
these hESC lines indicating that only minor differences exist.
These include three DNA binding proteins with potential role in
regulation of gene transcription: ZNF248, ZNF558 and SOHLH2
and proteins with potential membrane functions: MAGEE1,
LGALS14 and CLC (Charcot-Leyden crystal protein/Galectn-
10). ZNF248 is a Krueppel C2H2-type zinc-finger DNA binding
protein with potential role in transcriptional regulation [16].
ZNF558 is zinc finger DNA binding protein that also binds to
Rrp46 which is an exosome subunit and mRNA splicing/
Figure 3. Blastomere-derived hESC lines, SAB-113B and SAB-113D, can be differentiated into derivatives of all three germ layers. In
vitro differentiation of SAB-113B (A) and SAB-113D (B) into all 3 germ layers was confirmed by immunocytochemical analysis. aFP – a fetoprotein
(endoderm), b3T – bIII-tubulin (ectoderm), SMA – smooth muscle actin (mesoderm). The expression of derivatives of mesodermal – T (Brachyury
homolog), WT1 (Wilms tumor 1) and ACTA2 (smooth muscle actin, a2); endodermal – GATA4 (GATA binding protein 4), SOX17 (sex determining
region Y- box 17) and AFP (a-fetoprotein); and ectodermal – TUBB3 (tubulin, b3), NES (nestin) and PAX6 (paired box 6) genes were also confirmed by
RT-PCR analysis (C). In vivo differentiation was confirmed by histopathological analysis of teratoma tissue obtained 3 months post-initiation under the
dorsal flank of immunocompromised NOD/ SCID mice (D). Images of representative areas of H & E stained histological sections of the tumors:
derivatives of endoderm – epithelial tissue (Ep) (i); mesoderm – bone tissue fragment (B) (ii) and early cartilage tissue (C) (iii); and ectoderm –
neuroectodermal tissue (NE) (iv) and cells with melanin granules (red arrowheads) (iv, inset).
doi:10.1371/journal.pone.0026570.g003
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gene expression [17]. SOHLH2 is a spermatogenesis- and
oogenesis-specific basic helix–loop–helix (bHLH) transcription
factor implicated in regulation of early germ cell development
[18]. MAGEE1 gene is an X chromosome gene and encodes an a-
dystrobrevin-associated MAGE (melanoma-associated antigen)
protein (DAMAGE) that may have a signaling role in brain,
muscle, and peripheral nerve [19]. LGALS14 gene encodes a
galectin family protein predominantly expressed in placenta [20].
CLC gene encodes lysophospholipase, enzymes that regulate the
lysophospholipids in biological membranes [21]. It is related to the
galectin family and may also possess carbohydrate or IgE-binding
activities, and be associated with inflammation and some myeloid
leukemias [22].
A number of the genes, which showed 2–4 fold difference, do
not have known function. Other genes, that are either upregulated
(SFRS15, DAB1, LHFP, XPNPEP3, LY6E, SAR1A, EIF2S3 and
TRIM13) or downregulated (UBE3B, QK1, PASK, RAB3B)i n
Figure 4. Gene expression analysis of cleavage stage blastomere-derived and blastocyst stage ICM-derived hESC lines. Venn diagram
of microarray analysis showing differentially expressed genes after pairwise comparison of blastomere-derived (SBD) and whole embryo-derived
(WED) lines to reference RNA (A). Clustering tree generated by unsupervised hierarchical clustering analysis of summed median difference in the top
10,000 probe sets relative to reference RNA, and the normalized expression value of top 25 overexpressed and top 25 underexpressed genes (B). Blue
and red colors represent lower and higher expression, respectively. Pie charts depict distribution of uniquely expressed genes of blastomere-derived
(C) and whole embryo-derived (D) lines compared to reference RNA into known cellular biological processes such as cell cycle, regulation of
transcription, cell differentiation, signaling, cell migration, apoptosis, cell adhesion, and cytoskeleton organization.
doi:10.1371/journal.pone.0026570.g004
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assigned specific functions. For example, SFRS15 product binds to
carboxyl-terminal domain of the Rpb1 subunit of RNA polymer-
ase II and regulates the transcription [23,24]. DAB1 encodes a
scaffold protein which interacts with cytoplasmic tails of certain
low density lipoprotein (LDL) receptor family proteins that
regulate tyrosine kinase signaling and the remodeling of
cytoskeleton [25]. LHFP acts as a partner in HMGIC transloca-
tions in lipoma [26]. XPNPEP3 encodes a prolyl aminopeptidase
which is localized to mitochondria and also has ciliary function in
renal cells [27]. LY6E is a glycosylphosphatidylinositol-anchored
stem cell antigen that belongs to the Ly-6 family and is involved in
the self-renewal of erythroid progenitor cells [28,29]. SAR1A
encodes a guanosine triphosphatase which controls the assembly
and fission of vesicular coat protein complex II on cellular
membranes [30]. EIF2S3 encodes a translation initiation factor
that participates in the selection of the start codon. Phosphory-
lation of the a subunit of EIF2S3 at Ser-51 blocks the exchange of
Figure 5. Differentially expressed genes with fold change after direct comparison of cleavage stage blastomere-derived (SBD) and
blastocyst stage whole embryo-derived (WED) lines. Blue and red colors represent lower and higher expression, respectively.
doi:10.1371/journal.pone.0026570.g005
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PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26570Figure 6. Key stemness pathways in cleavage stage blastomere-derived and blastocyst stage ICM-derived lines. Ingenuity Pathways
Analysis showing that the key stemness pathways regulated by OCT4 and NANOG are active in both blastomere-derived (A, C) and ICM-derived (B)
hESC lines when compared to reference RNA.
doi:10.1371/journal.pone.0026570.g006
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and subsequent protein synthesis [31]. TRIM13 encodes endo-
plasmic reticulum E3 ubiquitin ligase involved in protein
degradation [32].
Transcripts downregulated in blastomere- relative to the whole
embryo-derived lines include UBE3B, that encodes a HECT-
domain E3 ubiquitin ligase which targets proteins for degradation
[33]; QK1 which product is RNA binding protein important for
normal development in vertebrates and regulates protein transla-
tion, RNA splicing, export from the nucleus, and stability [34,35];
PASK that encodes a PAS domain-containing protein kinase
involved in regulation of many intracellular signaling pathways in
response to both extrinsic and intrinsic stimuli [36] and RAB3B
that encodes one of the Ras-associated GTP-binding protein 3
family members that regulates secretory vesicle transport between
the Golgi apparatus and the plasma membrane [37].
The master regulators of human ESC stemness pathways are
transcription factors OCT4, SOX2 and NANOG [38]. They are
critically involved in establishment and maintenance of pluripotent
state in ESC and thus, closely associated with their stem cell
identity and function. To identify whether key stemness pathways
regulated by OCT4, SOX2 and NANOG are active in both
blastomere- and whole embryo-derived hESC lines we compared
expression of genes involved in these pathways to reference RNA
and, performed the pathway analysis using Ingenuity Pathways
Analysis platform. The analysis revealed that a number of genes
within these pathways such as OCT4, NANOG, SOX2 and
SALL4 were overexpressed in both blastomere- and whole
embryo-derived lines suggesting that hESC derived from two
developmentally different stages of human preimplantation
embryos, cleavage and blastocyst, maintain equivalent pluripotent
states (Fig. 6).
Discussion
In this study we have investigated whether differentiation status
of source cells within preimplantation embryo affects phenotype
and transcriptional profile of derived hESC lines. One of potential
hurdles in performing such an analysis is the presence of
differences between hESC cell lines that are not related to the
developmental stage of the cells of origin. These differences may
arise during cell line derivation and expansion as a result of in vitro
selection of specific phenotypic and molecular traits/characteris-
tics (‘‘culture effect’’). Another potential contributing factor to
hESC line heterogeneity is diverse genetic makeup of the embryos
due to outbred nature of human embryos. Consequently, despite
the expression of a common pluripotent phenotype, hESC lines
derived from single stage embryos, namely the ICM of the
blastocyst, have been reported to show significant variations in
both their molecular profiles and differentiation capacity
[39,40,41,42]. To minimize the effect of these factors on our
investigation, we used for this study multiple hESC lines with
different genetic backgrounds that were derived and cultured in
our laboratory under virtually identical, well controlled, condi-
tions. Indeed, our results suggest that once these culture-induced
factors are eliminated, hESC derived from different stages of
embryo development exhibit very little difference in their gene
expression profiles and maintain similar pluripotent phenotype.
One explanation for this finding is that although the source cells
from which hESC are derived are clearly at different develop-
mental stages, the process of hESC derivation selects for cells that
assume certain phenotypic and molecular state required for the
survival and self-renewal of pluripotent cells in culture.
One of the unique aspects of our analysis is that unlike the cell
lines generally used for gene expression studies that were often
derived and grown under heterogeneous culturing conditions and
have typically undergone extensive passaging and selection in
culture, lines used in this analysis were derived and grown under
identical defined conditions for limited number of passages, thus
minimizing culture-induced changes.
While overall transcriptional profile did not appear to be
significantly altered between blastomere and ICM-derived hESC,
we did detect a small number of genes with significantly different
expression between two groups. Out of these, only CLC, ZNF558
and LGALS14 genes were down-regulated more than 4 fold in
blastomere derived hESC lines. Interestingly, two of the genes
encode proteins from galectin (galaptin/S-lectin) family charac-
terized by presence of carbohydrate recognition domains and b-
galactosidase binding activity. CLC whose expression is downreg-
ulated 20 fold, encodes a lysophospholipase, an enzyme that
hydrolyzes lysophosphatidylcholine to glycerophosphocholine and
a free fatty acid and thus, contributes to the regulation of cell
membrane function. LGALS14 gene is predominantly expressed in
the placenta, an extraembryonic tissue that develops after
blastocyst implantation. The significance of their low abundance
in blastomere lines remains to be elucidated.
Our analysis does not preclude the possibility that there are
additional subtle differences in molecular and phenotypic profiles
between cleavage stage blastomere-derived and blastocyst stage
ICM-derived hESC lines. For example, epigenetic changes
including differences in DNA methylation patterns and X
chromosome inactivation have been shown to be affected by
different hESC states [43]. In addition, while we have not
observed differences in the ability of blastomere-derived and ICM-
derived hESC lines during spontaneous differentiation in vitro and
in vivo to give rise to cells from all three germ layers, efficiency of
differentiation and differentiation propensity towards specific cell
lineages have not been evaluated and are subject of current
investigation in our laboratory.
Nevertheless, overall our data strongly indicate that blastomere-
derived lines exhibit all the key characteristics of hESC derived
from ICM, including presence of pluripotency-associated path-
ways, ability to differentiate into cells from all three germ
layers, self-renewal and hESC-specific transcriptional profile. This
suggests that they represent a valid, embryo friendly, alternative to
whole embryo derived lines for any future applications such as cell
therapy and drug discovery.
Supporting Information
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